文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

特利加压素对成人感染性休克患者预后的影响:一项Meta分析

[Effect of terlipressin on prognosis of adult septic shock patients: a Meta-analysis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论现有证据提示特利加压素不能显著改善成人感染性休克患者病死率,但可能减少肾脏并发症,需强调肢体外周缺血事件增加的趋势。

该Meta分析纳入1980年1月至2019年12月间8项随机对照试验共811例成人感染性休克患者,比较特利加压素与去甲肾上腺素或其他血管升压药。结果显示两组病死率无显著差异(OR=0.89,95%CI 0.67-1.19,P=0.45);肢体外周缺血事件有增加趋势但无统计学差异(OR=10.81,95%CI 0.88-133.19,P=0.06);肾脏并发症发生率降低(OR=0.30,95%CI 0.09-0.96,P=0.04)。漏斗图分析提示病死率和严重不良事件的研究可能存在发表偏倚。

要点

  • 与去甲肾上腺素或其他血管升压药相比,特利加压素未显著改善成人感染性休克患者病死率(OR=0.89,95%CI 0.67-1.19,P=0.45)。
  • 特利加压素组肢体外周缺血事件有增加趋势但未达统计学差异(OR=10.81,95%CI 0.88-133.19,P=0.06),原文强调需重视该趋势。
  • 特利加压素组肾脏并发症发生率降低(OR=0.30,95%CI 0.09-0.96,P=0.04)。

适用人群与场景

  • 成人感染性休克患者,来自8项随机对照试验共811例。
  • 治疗组接受特利加压素,对照组接受去甲肾上腺素或其他血管升压药。

研究设计与关键结果

  • 研究类型为Meta分析,最终纳入8项随机对照试验,共811例患者;1项研究偏倚风险较低,6项偏倚风险不确定,1项偏倚风险较高。
  • 主要结局病死率:特利加压素组与对照组相比无显著改善(OR=0.89,95%CI 0.67-1.19,P=0.45)。
  • 肢体外周缺血事件发生率:特利加压素组有增加趋势但无统计学差异(OR=10.81,95%CI 0.88-133.19,P=0.06)。
  • 肾脏并发症发生率:特利加压素组降低(OR=0.30,95%CI 0.09-0.96,P=0.04)。
  • 漏斗图分析提示病死率和严重不良事件发生率的研究可能存在发表偏倚;肢体外周缺血事件和肾脏并发症的研究未发现明显发表偏倚。

证据类型、等级与局限

  • 证据类型:Meta分析,纳入8项随机对照试验。
  • 1项研究偏倚风险较低,6项研究偏倚风险不确定,1项研究偏倚风险较高。
  • 漏斗图分析提示病死率和严重不良事件发生率的研究可能存在发表偏倚。
  • 作者结论:现有证据提示特利加压素不能显著改善成人感染性休克患者病死率,但可能减少肾脏并发症;特利加压素组肢体外周缺血事件增加的趋势需要强调。

对床旁实践的改变

  • 作者认为,现有证据提示特利加压素不能显著改善成人感染性休克患者病死率,但可能减少肾脏并发症。
  • 作者强调,特利加压素组肢体外周缺血事件增加的趋势需要重视。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
  • 另有 3 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the effect of terlipressin on prognosis of adult septic shock patients.

METHODS: All randomized controlled clinical trials (RCT) of terlipressin in the treatment of adult septic shock patients from January 1980 to December 2019 were retrieved from CNKI, Wanfang, SinoMed, PubMed, Embase, Springer Link, Cochrane Library, Google Scholar, and etc. Patients in the treatment group received terlipressin while patients in the control group received norepinephrine or other vasopressors. Main outcome indicator was mortality. Secondary outcome indicators included the incidence of severe adverse events, limb peripheral ischemic events and renal complications. Literature screening, data extraction and quality evaluation were conducted by two researchers respectively. Meta-analysis was performed with RevMan 5.3 software. Funnel plot was used to analyze the publication bias.

RESULTS: A total of 507 related literatures were retrieved. According to the inclusion and exclusion criteria, 8 RCT studies were finally included, with a total of 811 patients. One study was considered to have a lower risk of bias, 6 studies had uncertain risk of bias, and 1 study had a higher risk of bias. The Meta-analysis showed that terlipressin did not significantly improve the mortality of septic shock patients compared with the control group [odds ratio (OR) = 0.89, 95% confidence interval (95%CI) was 0.67-1.19, P = 0.45]; increased the incidence of severe adverse events (OR = 2.98, 95%CI was 1.99-4.45, P < 0.000 01); there was a tendency to increase the incidence of limb peripheral ischemic events, but without statistical difference (OR = 10.81, 95%CI was 0.88-133.19, P = 0.06); and reduced the incidence of renal complications (OR = 0.30, 95%CI was 0.09-0.96, P = 0.04). Funnel plot analysis indicated that there might be publication bias in a study on case fatality and incidence of serious adverse events in the included literature. No significant publication bias was found in studies on the incidence of limb peripheral ischemic events and the incidence of kidney-related complications.

CONCLUSIONS: The available evidence suggests that terlipressin could not significantly improve mortality in adult's septic shock patients, but it may reduce the incidence of renal complications. A tendency to increase the incidence of limb peripheral ischemic events in the terlipressin-treated group needs to be emphasized.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Li W, Pan P, Wang Y, et al. [Effect of terlipressin on prognosis of adult septic shock patients: a Meta-analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32274994. doi:10.3760/cma.j.cn121430-20200210-00025

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。